The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

Falck, Jacob, Mailand, Niels, Syljuåsen, Randi G., Bartek, Jiri, Lukas, Jiri·2001·Nature
DOI 10.1038/35071124

Cited by (1,000)

Items 201–300 of 1,000

  1. Tumor Suppressor CHK2: Regulator of DNA Damage Response and Mediator of Chromosomal Stability
    Ailine Stolz, Norman Ertych, Holger Bastians · 2010 · Clinical Cancer Research
  2. Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients
    Outi Kilpivaara, Jiřina Bártková, Hannaleena Eerola, Kirsi Syrjäkoski, Pia Vahteristo, Jiri Lukas, CARL P. BLOMQVIST, Kaija Holli, Päivi Heikkilä, Guido Sauter et al. · 2004 · International Journal of Cancer
  3. DNA-damage response network at the crossroads of cell-cycle checkpoints, cellular senescence and apoptosis
    Estelle Schmitt, Claudie Paquet, Myriam Beauchemin, Richard Bertrand · 2007 · Journal of Zhejiang University SCIENCE B
  4. Sensing, signaling, and responding to DNA damage: Organization of the checkpoint pathways in mammalian cells
    Lei Li, Lee Zou · 2004 · Journal of Cellular Biochemistry
  5. Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway
    Jacob Falck, Claudia Lukas, Marina Protopopova, Jiri Lukas, Galina Selivanova, Jiří Bártek · 2001 · Oncogene
  6. Dealing with DNA damage: Relationships between checkpoint and repair pathways
    Daniël O. Warmerdam, Roland Kanaar · 2009 · Mutation Research/Reviews in Mutation Research
  7. MicroRNAs in the Imprinted DLK1-DIO3 Region Repress the Epithelial-to-Mesenchymal Transition by Targeting the TWIST1 Protein Signaling Network
    Christopher L. Haga, Donald G. Phinney · 2012 · Journal of Biological Chemistry
  8. The Intra-S Checkpoint Responses to DNA Damage
    Divya Iyer, Nick Rhind · 2017 · Genes
  9. Phosphorylation of Human Rad9 Is Required for Genotoxin-activated Checkpoint Signaling
    Pia Roos‐Mattjus, Kevin M. Hopkins, Andrea J. Oestreich, Benjamin T. Vroman, Kenneth L. Johnson, Stephen Naylor, Howard B. Lieberman, Larry M. Karnitz · 2003 · Journal of Biological Chemistry
  10. DNA Double Strand Break Repair: A Radiation Perspective
    Joy N. Kavanagh, Kelly M. Redmond, Giuseppe Schettino, Kevin M. Prise · 2013 · Antioxidants and Redox Signaling
  11. MDC1/NFBD1: a key regulator of the DNA damage response in higher eukaryotes
    Manuel Stucki, Stephen P. Jackson · 2004 · DNA repair
  12. Relative Contribution of DNA Repair, Cell Cycle Checkpoints, and Cell Death to Survival after DNA Damage in Drosophila Larvae
    Burnley R. Jaklevic, Tin Tin Su · 2004 · Current Biology
  13. Multimodal selenium nanoshell-capped Au@mSiO2 nanoplatform for NIR-responsive chemo-photothermal therapy against metastatic breast cancer
    Thiruganesh Ramasamy, Hima Bindu Ruttala, Pasupathi Sundaramoorthy, Bijay Kumar Poudel, Yu Seok Youn, Sae‐Kwang Ku, Han‐Gon Choi, Chul Soon Yong, Jong Oh Kim · 2018 · NPG Asia Materials
  14. Viral Oncogene–Induced DNA Damage Response Is Activated in Kaposi Sarcoma Tumorigenesis
    Sonja Koopal, Johanna Furuhjelm, Annika Järviluoma, Sari Jäämaa, Pawan Pyakurel, Christel Pussinen, Maria Wirzenius, Peter Biberfeld, Kari K. Alitalo, Marikki Laiho et al. · 2007 · PLoS Pathogens
  15. DUAL SPECIFICITY PROTEIN PHOSPHATASES: Therapeutic Targets for Cancer and Alzheimer's Disease
    Alexander P. Ducruet, Andreas Vogt, Peter Wipf, John Stephen Lazo · 2004 · The Annual Review of Pharmacology and Toxicology
  16. CDK targeting of NBS1 promotes DNA‐end resection, replication restart and homologous recombination
    Jacob Falck, Josep V. Forment, Julia Coates, Martin Mistrík, Jiri Lukas, Jiří Bártek, Stephen P. Jackson · 2012 · EMBO Reports
  17. Checking in on Cds1 (Chk2): A checkpoint kinase and tumor suppressor
    Clare H. McGowan · 2002 · BioEssays
  18. Activation of ATM and Chk2 kinases in relation to the amount of DNA strand breaks
    Giacomo Buscemi, Paola Perego, Nives Carenini, Makoto Nakanishi, Luciana Chessa, Junjie Chen, Kum Kum Khanna, Domenico Delia · 2004 · Oncogene
  19. Role of Checkpoint Kinase 1 in Preventing Premature Mitosis in Response to Gemcitabine
    Meredith Ann Morgan, Leslie A. Parsels, Joshua D. Parsels, Alefiyah K. Mesiwala, Jonathan Maybaum, Theodore Steven Lawrence · 2005 · Cancer Research
  20. Cdk2 is required for p53-independent G2/M checkpoint control
    Chung, Jon H., Bunz, Fred · 2010 · PLoS Genetics
  21. DNA repair genes are selectively mutated in diffuse large B cell lymphomas
    Noel F.C.C. de Miranda, Roujun Peng, Konstantinos E. Georgiou, Chenglin Wu, Elin Falk-Sörqvist, Mattias Berglund, Longyun Chen, Zhibo Gao, Kristina Lagerstedt‐Robinson, Susana Lisboa et al. · 2013 · The Journal of Experimental Medicine
  22. The DNA damage response during mitosis
    Anne Margriet Heijink, Małgorzata Krajewska, Marcel A.T.M. van Vugt · 2013 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
  23. Abrogation of the S Phase DNA Damage Checkpoint Results in S Phase Progression or Premature Mitosis Depending on the Concentration of 7-Hydroxystaurosporine and the Kinetics of Cdc25C Activation
    Ethan A. Kohn, Nicola D. Ruth, Mary Kay Brown, Mark Livingstone, Alan R. Eastman · 2002 · Journal of Biological Chemistry
  24. Cordycepin induces cell cycle arrest and apoptosis by inducing DNA damage and up-regulation of p53 in Leukemia cells
    Yuanhong Liao, Jianya Ling, Guoying Zhang, Fengjun Liu, Sheng‐ce Tao, Ze‐Guang Han, Sai‐Juan Chen, Zhu Chen, Huangying Le · 2015 · Cell Cycle
  25. Checkpoint Kinase 1 Regulates Diallyl Trisulfide-induced Mitotic Arrest in Human Prostate Cancer Cells
    Anna Herman-Antosiewicz, Shivendra Vikram Singh · 2005 · Journal of Biological Chemistry
  26. Regulation of CHK2 by DNA-dependent Protein Kinase
    Jia Li, David F. Stern · 2005 · Journal of Biological Chemistry
  27. Chemistry and Biology of Acylfulvenes: Sesquiterpene-Derived Antitumor Agents
    Marina Tanasova, Shana J. Sturla · 2012 · Chemical Reviews
  28. Regulation of the cellular DNA double-strand break response
    Kendra L. Cann, Geoffrey G. Hicks · 2007 · Biochemistry and Cell Biology
  29. Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML
    Fei Yang, Nicola Long, Tauangtham Anekpuritanang, Daniel Bottomly, Jonathan C. Savage, Tiffany L. Lee, Jose M. Solis-Ruiz, Uma Borate, Beth Wilmot, Cristina E. Tognon et al. · 2021 · Blood
  30. Ataxia-telangiectasia-mutated (ATM) Is a T-antigen Kinase That Controls SV40 Viral Replication in Vivo
    Yuling Shi, Gerald E. Dodson, Sophie Shaikh, Kathleen Rundell, Randal S. Tibbetts · 2005 · Journal of Biological Chemistry
  31. The Effect of CHEK2 Variant I157T on Cancer Susceptibility: Evidence from a Meta-Analysis
    Feifei Han, Changlong Guo, Lihong Liu · 2013 · DNA and Cell Biology
  32. ATR Is Not Required for p53 Activation but Synergizes with p53 in the Replication Checkpoint
    Paul Nghiem, Peter K. Park, Yong-son Kim, Bimal N. Desai, Stuart L. Schreiber · 2002 · Journal of Biological Chemistry
  33. MicroRNAs in the DNA Damage/Repair Network and Cancer
    Alessandra Tessitore, Germana Cicciarelli, Filippo Del Vecchio, Agata Gaggiano, Daniela Verzella, Mariafausta Fischietti, Davide Vecchiotti, Daria Capece, Francesca Zazzeroni, Edoardo Alesse · 2014 · International Journal of Genomics
  34. Genetic determinants at the interface of cancer and neurodegenerative disease
    Luc G.T. Morris, Selvaraju Veeriah, Timothy An-thy Chan · 2010 · Oncogene
  35. The Chk1-mediated S-phase Checkpoint Targets Initiation Factor Cdc45 via a Cdc25A/Cdk2-independent Mechanism
    Peijun Liu, Laura R. Barkley, Tovah A. Day, Xiaohui Bi, Damien Slater, Mark G. Alexandrow, Heinz‐Peter Nasheuer, Cyrus Vaziri · 2006 · Journal of Biological Chemistry
  36. How adeno-associated virus Rep78 protein arrests cells completely in S phase
    C. Berthet, Kenneth Raj, Philippe Saudan, Peter Beard · 2005 · Proceedings of the National Academy of Sciences
  37. DNA damage responses and their many interactions with the replication fork
    Paul R. Andreassen, Gary P. H. Ho, Alan D. D’Andrea · 2006 · Carcinogenesis
  38. TTK/hMps1 Participates in the Regulation of DNA Damage Checkpoint Response by Phosphorylating CHK2 on Threonine 68
    Jen‐Hsuan Wei, Yi‐Fan Chou, Yi-Hung Ou, Yen-Hsiu Yeh, Shiaw‐Wei Tyan, Te-Ping Sun, Chen‐Yang Shen, Sheau-Yann Shieh · 2004 · Journal of Biological Chemistry
  39. Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells
    Chiara Laezza, Simona Pisanti, Elvira Crescenzi, Maurizio Bifulco · 2006 · FEBS Letters
  40. Caffeine and human DNA metabolism: the magic and the mystery
    William K. Kaufmann, Timothy P. Heffernan, Lea M. Beaulieu, Sharon Doherty, Alexandra R. Frank, Yingchun Zhou, Miriam F. Bryant, Tong Zhou, Douglas D. Luche, Nana Nikolaishvili-Feinberg et al. · 2003 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
  41. Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase–activated protein kinase 2 in mediating DNA damage–induced cell cycle arrest: implications for cancer therapy
    Zhan Xiao, John Xue, Thomas J. Sowin, Haiying Zhang · 2006 · Molecular Cancer Therapeutics
  42. p53-based cancer therapies: is defective p53 the Achilles heel of the tumor?
    Aime A. Levesque, Alan R. Eastman · 2006 · Carcinogenesis
  43. Targeting the replication stress response through synthetic lethal strategies in cancer medicine
    Natalie Y.L. Ngoi, Melissa M. Pham, David S.P. Tan, Timothy Anthony Yap · 2021 · Trends in cancer
  44. DNA breakage and induction of DNA damage response proteins precede the appearance of visible mutant huntingtin aggregates
    Jennifer L. Illuzzi, Sarah Yerkes, Hetal Parekh‐Olmedo, Eric Brian Kmiec · 2008 · Journal of Neuroscience Research
  45. How Tyrosine 15 Phosphorylation Inhibits the Activity of Cyclin-dependent Kinase 2-Cyclin A
    Julie P. I. Welburn, Julie A. Tucker, Tim Johnson, Lisa M Lindert, Marc Morgan, Antony C. Willis, Martin E. M. Noble, Jane Endicott · 2006 · Journal of Biological Chemistry
  46. The role of Plk3 in oncogenesis
    Christina Helmke, Sven Becker, Klaus Strebhardt · 2015 · Oncogene
  47. CHEK2 Mutations Affecting Kinase Activity Together With Mutations in TP53 Indicate a Functional Pathway Associated with Resistance to Epirubicin in Primary Breast Cancer
    Ranjan Chrisanthar, Stian Knappskog, Erik Løkkevik, Gun B. Anker, Bjørn Østenstad, Steinar Lundgren, Elisabet Ognedal Berge, Terje Risberg, Ingvil Mjaaland, Lovise Mæhle et al. · 2008 · PLoS ONE
  48. DNA Methyltransferase 1 Knockdown Activates a Replication Stress Checkpoint
    Alexander Unterberger, Stephen D. Andrews, Ian C.G. Weaver, Moshe Szyf A · 2006 · Molecular and Cellular Biology
  49. Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome
    Jaakko S. Tyrmi, Riikka K. Arffman, Natàlia Pujol‐Gualdo, Venla Kurra, Laure C. Morin-Papunen, Eeva Sliz, FinnGen, Terhi Piltonen, Triin Laisk, Johannes Kettunen et al. · 2021 · Human Reproduction
  50. Involvement of Nucleotide Excision and Mismatch Repair Mechanisms in Double Strand Break Repair
    Ye Zhang, Larry H. Rohde, Honglu Wu · 2009 · Current Genomics
  51. Molecular Targets in Cellular Response to Ionizing Radiation and Implications in Space Radiation Protection
    Mauro Belli, Orazio Sapora, Maria Antonella Tabocchini · 2002 · Journal of Radiation Research
  52. Mitogen-Activated Protein Kinase–Activated Protein Kinase 2 in Neuroinflammation, Heat Shock Protein 27 Phosphorylation, and Cell Cycle: Role and Targeting
    Fadi Gurgis, William A. Ziaziaris, Lenka Munoz · 2013 · Molecular Pharmacology
  53. ATM/ATR checkpoint activation downregulates CDC25C to prevent mitotic entry with uncapped telomeres
    Maria Thanasoula, José Miguel Escandell, Natsuko Suwaki, Madalena Tarsounas · 2012 · The EMBO Journal
  54. Regulation of DNA replication by the S-phase DNA damage checkpoint
    Nicholas A. Willis, Nick Rhind · 2009 · Cell Division
  55. Potentiation of Cytotoxicity of Topoisomerase I Poison by Concurrent and Sequential Treatment with the Checkpoint Inhibitor UCN-01 Involves Disparate Mechanisms Resulting in Either p53-Independent Clonogenic Suppression or p53-Dependent Mitotic Catastrophe
    Archie N. Tse, Gary K. Schwartz · 2004 · Cancer Research
  56. Limited relevance of the CHEK2 gene in hereditary breast cancer
    Michael R. Dufault, Beate Betz, Barbara Wappenschmidt, Wera Hofmann, Katrin Bandick, Astrid Golla, Andrea Pietschmann, Caroline Nestle-Krämling, Kerstin Rhiem, Christine Hüttner et al. · 2004 · International Journal of Cancer
  57. Triggering mitosis
    Adrijana Crncec, Helfrid Hochegger · 2019 · FEBS Letters
  58. Regulation of Human Cdc25A Stability by Serine 75 Phosphorylation Is Not Sufficient to Activate a S-phase Checkpoint
    Anastasia R. Goloudina, Hiroshi Yamaguchi, Daria B. Chervyakova, Ettore Appella, Albert J. Fornace, Dmitry V. Bulavin · 2003 · Cell Cycle
  59. Gene expression profiling of monkeypox virus-infected cells reveals novel interfaces for host-virus interactions
    Abdulnaser Alkhalil, Rasha Hammamieh, Justin P. Hardick, Mohamed Ait Ichou, Marti Jett, Sofi M Ibrahim · 2010 · Virology Journal
  60. Patients Resistant Against PSMA-Targeting α-Radiation Therapy Often Harbor Mutations in DNA Damage-Repair–Associated Genes
    Clemens Kratochwil, Frederik Lars Giesel, Claus Peter Heußel, Daniel N. Kazdal, Volker Endris, Cathleen Nientiedt, Frank Bruchertseifer, Maximilian Kippenberger, Hendrik G. Rathke, Jonas Leichsenring et al. · 2019 · Journal of Nuclear Medicine
  61. A Role for Homologous Recombination and Abnormal Cell-Cycle Progression in Radioresistance of Glioma-Initiating Cells
    Yi Chieh Lim, Tara Laurine Roberts, Bryan W. Day, Angus Silas Harding, Sergei Kozlov, Amanda Wraith Kijas, Kathleen S. Ensbey, David Walker, Martin Francis Lavin · 2012 · Molecular Cancer Therapeutics
  62. Genetic contributions to Parkinson's disease
    Yue Ming Huang, Linda Cheung, Dominic B. Rowe, Glenda Margaret Halliday · 2004 · Brain Research Reviews
  63. Association of two mutations in the CHEK2 gene with breast cancer
    Natalia Viktorovna Bogdanova, Natalia Enβen‐Dubrowinskaja, Sergei Feshchenko, Gennady I. Lazjuk, Yuriy Rogov, Olaf Dammann, Michael Bremer, Johann Hinrich Karstens, Christof Sohn, Thilo Dörk · 2005 · International Journal of Cancer
  64. Murine Wee1 Plays a Critical Role in Cell Cycle Regulation and Pre-Implantation Stages of Embryonic Development
    Yohei Tominaga, Cuiling Li, Ruihong Wang, Chu‐Xia Deng · 2006 · International Journal of Biological Sciences
  65. Differential Contribution of Inhibitory Phosphorylation of CDC2 and CDK2 for Unperturbed Cell Cycle Control and DNA Integrity Checkpoints
    Jeremy P.H. Chow, Wai Yi Siu, Horace T. B. Ho, Hoi Tang Ma, Chui Chui Ho, Randy Y.C. Poon · 2003 · Journal of Biological Chemistry
  66. CHEK2 contribution to hereditary breast cancer in non-BRCAfamilies
    Alexis Desrichard, Yannick Bidet, Nancy A. Uhrhammer, Yves‐Jean Bignon · 2011 · Breast Cancer Research
  67. Genetic instability in cancer cells by impaired cell cycle checkpoints
    Makoto Nakanishi, Midori Shimada, Hiroyuki Niida · 2006 · Cancer Science
  68. Radiation and the cell cycle, revisited
    George David Wilson · 2004 · Cancer and Metastasis Reviews
  69. ATM signaling and 53BP1
    Omar Zgheib, Yentram Huyen, Richard A. DiTullio, Andrew R. Snyder, Monica Venere, Elena S. Stavridi, Thanos D. Halazonetis · 2005 · Radiotherapy and Oncology
  70. MicroRNAs, the DNA damage response and cancer
    Maikel D. Wouters, Dik C. van Gent, Jan H.J. Hoeijmakers, Joris Pothof · 2011 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
  71. Ewing Sarcoma Protein: A Key Player in Human Cancer
    Maria Paola Paronetto · 2013 · International Journal of Cell Biology
  72. Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts
    Daphne W. Bell, Sang Ho Kim, Andrew K. Godwin, Taryn A. Schiripo, Patricia L. Harris, Sara M. Haserlat, Doke C.R. Wahrer, Christopher A. Haiman, Mary B. Daly, Kristin Baker Niendorf et al. · 2007 · International Journal of Cancer
  73. Methylator-induced, Mismatch Repair-dependent G2Arrest Is Activated through Chk1 and Chk2
    Aaron W. Adamson, Dillon I. Beardsley, Wan-Ju Kim, Yajuan Gao, Rathinasamy Baskaran, Kevin D. Brown · 2005 · Molecular Biology of the Cell
  74. Therapeutic Targeting the Cell Division Cycle 25 (CDC25) Phosphatases in Human Acute Myeloid Leukemia — The Possibility to Target Several Kinases through Inhibition of the Various CDC25 Isoforms
    Annette K. Brenner, Håkon Reikvam, Antonio Lavecchia, Øystein Bruserud · 2014 · Molecules
  75. Engineering of caveolae-specific self-micellizing anticancer lipid nanoparticles to enhance the chemotherapeutic efficacy of oxaliplatin in colorectal cancer cells
    Pasupathi Sundaramoorthy, Thiruganesh Ramasamy, Siddhartha Kumar Mishra, Keun‐Yeong Jeong, Chul Soon Yong, Jong Oh Kim, Hwan Mook Kim · 2016 · Acta Biomaterialia
  76. RAD51C facilitates checkpoint signaling by promoting CHK2 phosphorylation
    Sophie Badie, Chunyan Liao, Maria Thanasoula, Paul R. Barber, Mark A. Hill, Madalena Tarsounas · 2009 · The Journal of Cell Biology
  77. CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer.
    Peilin Zhang, Jie Wang, Weiyi Gao, Bao‐Zhu Yuan, John Rogers, Eddie Reed · 2004 · Molecular Cancer
  78. Rare, evolutionarily unlikely missense substitutions in CHEK2contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study
    Florence Le Calvez‐Kelm, Fabienne Lesueur, Francesca Damiola, Maxime Vallée, Catherine Voegele, Davit Babikyan, Geoffroy Durand, Nathalie Forey, Sandrine McKay‐Chopin, Nivonirina Ranoroarivony Robinot et al. · 2011 · Breast Cancer Research
  79. APOBEC3A damages the cellular genome during DNA replication
    Abby M. Green, Sébastien Landry, Konstantin Budagyan, Daphne C. Avgousti, Sophia Z. Shalhout, Ashok S. Bhagwat, Matthew D. Weitzman · 2016 · Cell Cycle
  80. ATM is required for the cellular response to thymidine induced replication fork stress
    Emma Bolderson, Jennifer Scorah, Thomas Helleday, Carl Smythe, Mark Meuth · 2004 · Human Molecular Genetics
  81. NER initiation factors, DDB2 and XPC, regulate UV radiation response by recruiting ATR and ATM kinases to DNA damage sites
    Ray, Alo, Milum, Keisha, Battu, Aruna, Wani, Gulzar, Wani, Altaf A. · 2013 · DNA Repair
  82. CHEK2 I157T associates with familial and sporadic colorectal cancer
    Outi Kilpivaara, P Alhopuro, P Vahteristo, Lauri A. Aaltonen, Heli A. Nevanlinna · 2006 · Journal of Medical Genetics
  83. The CHEK2 I157T Variant and Colorectal Cancer Susceptibility: A Systematic Review and Meta-analysis
    Chuan Liu, Qingshui Wang, Yajie Wang · 2012 · Asian Pacific Journal of Cancer Prevention
  84. Regulation of mitosis via mitotic kinases: new opportunities for cancer management
    Travis L. Schmit, Nihal Ahmad · 2007 · Molecular Cancer Therapeutics
  85. Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1
    Darren Krause, Jyoti C Jonnalagadda, Magtouf Hnaidi Gatei, Herman H.W. Silljé, Bin‐Bing S. Zhou, Erich A. Nigg, Kum Kum Khanna · 2003 · Oncogene
  86. Sirtuin 7 promotes cellular survival following genomic stress by attenuation of DNA damage, SAPK activation and p53 response
    Shashi Kiran, Vineesha Oddi, Gayatri Ramakrishna · 2014 · Experimental Cell Research
  87. Oxidative stress, cell cycle arrest, DNA damage and apoptosis in adult zebrafish (Danio rerio) induced by tris(1,3-dichloro-2-propyl) phosphate
    Hanyan Chen, Pingping Wang, Zhongkun Du, Guowei Wang, Shixiang Gao · 2017 · Aquatic Toxicology
  88. Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?
    Cezary Cybulski, Dominika Wokołorczyk, Józef Kładny, Grzegorz Kurzwaski, Joanna Suchy, Ewa A. Grabowska, Jacek Gronwald, Tomasz Huzarski, Tomasz Byrski, Bohdan Górski et al. · 2006 · European Journal of Human Genetics
  89. DNA Damage and Repair in Vascular Disease
    Anna Uryga, Kelly Gray, Martin R. Bennett · 2015 · Annual Review of Physiology
  90. Response to DNA damage of CHEK2 missense mutations in familial breast cancer
    Wendy Roeb, Jake Higgins, Mary‐Claire King · 2012 · Human Molecular Genetics
  91. Novel Checkpoint Response to Genotoxic Stress Mediated by Nucleolin-Replication Protein A Complex Formation
    Kyung Kim, Diana D. Dimitrova, Kristine M. Carta, Anjana D. Saxena, Mariza Daras, James A. Borowiec · 2005 · Molecular and Cellular Biology
  92. Alternative splicing and mutation status of CHEK2 in stage III breast cancer
    Vidar Staalesen, Jacob Falck, Stephanie Beate Geisler, Jiřina Bártková, Anne‐Lise Børresen‐Dale, Jiri Lukas, Johan Richard Lillehaug, Jiří Bártek, Per Eystein Lønning · 2004 · Oncogene
  93. The Mre11 Complex Mediates the S-Phase Checkpoint through an Interaction with Replication Protein A
    Erin E. Olson, Christian J. Nievera, Enbo Liu, Alan Yueh‐Luen Lee, Longchuan Chen, Xiaohua Wu · 2007 · Molecular and Cellular Biology
  94. Characterization of a novel ATR-dependent, Chk1-independent, intra-S-phase checkpoint that suppresses initiation of replication inXenopus
    Maria Gloria Luciani, Maren Oehlmann, J. Julian Blow · 2004 · Journal of Cell Science
  95. CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomas
    Frederic Tort, Silvia F. Hernandez, Sı́lvia Beà, Antonio Martı́nez, Manel Esteller, James Gordon Herman, Xavier Puig, Emma Camacho, Montse Sánchez, Iracema Nayach et al. · 2002 · Blood
  96. Checkpoint Kinase 2 (Chk2) Monomers or Dimers Phosphorylate Cdc25C after DNA Damage Regardless of Threonine 68 Phosphorylation
    Jinwoo Ahn, Carol L. Prives · 2002 · Journal of Biological Chemistry
  97. The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo
    Maurice Reimann, Christoph Loddenkemper, Cornelia Rudolph, Ines Schildhauer, Bianca Teichmann, Harald Stein, Brigitte Schlegelberger, Bernd Dörken, Clemens A. Schmitt · 2007 · Blood
  98. The p53-inducible gene 3 (PIG3) contributes to early cellular response to DNA damage
    J-H Lee, Yang Joo Kang, V Khare, Z-Y Jin, M-Y Kang, Young Mi Yoon, J-W Hyun, M-H. Chung, S-I Cho, Jae Yeoul Jun et al. · 2009 · Oncogene
  99. Alterations in Cell Cycle and Induction of Apoptotic Cell Death in Breast Cancer Cells Treated withα-Mangostin Extracted from Mangosteen Pericarp
    Hitomi Kurose, Masaaki Shibata, Munekazu Iinuma, Yoshinori Otsuki · 2012 · BioMed Research International
  100. Phosphorylation at Serine 75 Is Required for UV-mediated Degradation of Human Cdc25A Phosphatase at the S-phase Checkpoint
    Ingo Hassepass, Renate Voit, Ingrid Hoffmann · 2003 · Journal of Biological Chemistry